603669 灵康药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-1.739-14.668-15.1044.48511.460
总资产报酬率 ROA (%)-1.032-8.707-8.9642.5206.915
投入资产回报率 ROIC (%)-1.081-9.094-9.2602.6226.384

边际利润分析
销售毛利率 (%)57.05446.67267.80979.37683.941
营业利润率 (%)-22.389-75.690-65.2269.60818.057
息税前利润/营业总收入 (%)-21.490-76.447-65.67010.38518.303
净利润/营业总收入 (%)-20.871-76.967-67.7118.90215.991

收益指标分析
经营活动净收益/利润总额(%)110.583103.96389.06648.03155.729
价值变动净收益/利润总额(%)38.6559.6284.30023.9160.272
营业外收支净额/利润总额(%)-6.3201.3080.069-0.920-0.830

偿债能力分析
流动比率 (X)6.7173.6263.7432.7562.787
速动比率 (X)6.1913.3933.5812.6762.692
资产负债率 (%)38.41942.69038.84941.98045.517
带息债务/全部投入资本 (%)34.82539.19036.01039.555--
股东权益/带息债务 (%)184.956153.346176.783150.667135.628
股东权益/负债合计 (%)160.288134.249157.405138.208119.699
利息保障倍数 (X)49.727-310.910164.74512.00646.310

营运能力分析
应收账款周转天数 (天)70.416143.506134.24571.7070.000
存货周转天数 (天)157.095181.612194.865142.3290.000